enoxaparin sodium
Generic: enoxaparin sodium
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
enoxaparin sodium
Generic Name
enoxaparin sodium
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION
Routes
Active Ingredients
enoxaparin sodium 40 mg/.4mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-535
Product ID
63323-535_53e20cb1-9e79-4c45-a5a7-62c3904df818
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA020164
Listing Expiration
2027-12-31
Marketing Start
2019-06-18
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323535
Hyphenated Format
63323-535
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
enoxaparin sodium (source: ndc)
Generic Name
enoxaparin sodium (source: ndc)
Application Number
NDA020164 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 40 mg/.4mL
Packaging
- 10 CELLO PACK in 1 CARTON (63323-535-87) / 1 SYRINGE in 1 CELLO PACK (63323-535-01) / .4 mL in 1 SYRINGE
Packages (1)
Ingredients (1)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "53e20cb1-9e79-4c45-a5a7-62c3904df818", "openfda": {"unii": ["8NZ41MIK1O"], "rxcui": ["854228", "854235", "854238", "854241", "854245", "854248", "854252", "854255"], "spl_set_id": ["21b095d1-5ade-43e9-9114-30fbfb2331c9"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 CELLO PACK in 1 CARTON (63323-535-87) / 1 SYRINGE in 1 CELLO PACK (63323-535-01) / .4 mL in 1 SYRINGE", "package_ndc": "63323-535-87", "marketing_start_date": "20190618"}], "brand_name": "Enoxaparin Sodium", "product_id": "63323-535_53e20cb1-9e79-4c45-a5a7-62c3904df818", "dosage_form": "INJECTION", "pharm_class": ["Heparin", "Low-Molecular-Weight [CS]", "Low Molecular Weight Heparin [EPC]"], "product_ndc": "63323-535", "generic_name": "enoxaparin sodium", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Enoxaparin Sodium", "active_ingredients": [{"name": "ENOXAPARIN SODIUM", "strength": "40 mg/.4mL"}], "application_number": "NDA020164", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20190618", "listing_expiration_date": "20271231"}